| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 472,643 | 488,911 | 496,488 | 465,536 | | Cost of Revenue | 354,374 | 360,721 | 366,887 | 373,348 | | | Gross Profit | 118,269 | 128,190 | 129,601 | 92,188 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 109,545 | 109,482 | 108,053 | 123,599 | | Non Recurring | (13) | 16 | (3) | (161) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,056 | 18,692 | 21,551 | (31,250) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,043 | 539 | 403 | 170 | | Earnings Before Interest And Taxes | 10,780 | 19,231 | 21,954 | (31,080) | | Interest Expense | 6,922 | 6,466 | 1,936 | 8,071 | | Income Before Tax | 3,858 | 12,765 | 20,018 | (39,151) | | Income Tax Expense | 1,501 | 4,907 | 8,955 | (6,324) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,357 | 7,858 | 11,063 | (32,827) | | | Non-recurring Events | | Discontinued Operations | (233) | (123) | (154) | (440) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,124 | 7,735 | 10,909 | (33,267) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,124 | $7,735 | $10,909 | ($33,267) |
|
0.02% Nasdaq 
Income Statement
